Elizabeth Smyth

National Health Service — United Kingdom

Medicine · Health Sciences

43h-index19.2kcitations288works9.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(163), Esophageal Cancer Research and Treatment(118), Colorectal Cancer Treatments and Studies(53), Gastrointestinal Tumor Research and Treatment(45), Cancer Immunotherapy and Biomarkers(42)

Publications287 total

Immune Checkpoint Inhibitor Therapy for Advanced, Unresectable Esophageal Squamous Cell Carcinoma: A Series of Patient-level Meta-analyses From Phase III Trials
Clinical Oncology·2026
Promising investigational agents for gastro-oesophageal junction adenocarcinoma
Expert Opinion on Investigational Drugs·2025
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis
European Journal of Cancer·2025Open Access
Population screening for Helicobacter pylori to reduce gastric cancer – Authors' reply
The Lancet·2025Open Access
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer
ESMO Open·2025· 1 citedOpen Access
Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise
Gut·2025Open Access
PD-1/PD-L1 inhibitors in advanced, unresectable esophageal squamous-cell carcinoma: A meta-analysis of their effects across patient subgroups
Critical Reviews in Oncology/Hematology·2025· 2 cited
Research training, barriers, and career development needs of early-career investigators in oncology: an EORTC survey-based study
ESMO Gastrointestinal Oncology·2025· 1 citedOpen Access
United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2024
Clinical Oncology·2025
Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre Study
Cancers·2025· 1 citedOpen Access
FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma
Cancer Treatment Reviews·2025· 3 citedOpen Access
Gastric cancer
The Lancet·2025· 136 citedOpen Access
Abstract B064: Utility of ctDNA assessment after six weeks of immunotherapy to predict radiological response in advanced esophageal cancer
Cancer Immunology Research·2025
How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task force
Cancer Treatment Reviews·2025· 8 citedOpen Access
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight
Drugs·2025· 6 cited
Expanding therapeutic options targeting claudin-18.2
The Lancet Oncology·2025· 1 cited
Contributors
Elsevier eBooks·2025
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer
ESMO Open·2024· 14 citedOpen Access
REsolution of Symptoms afTer Oesophago-gastric cancer REsection delphi (RESTOREd)—standardizing the definition, investigation and management of gastrointestinal symptoms and conditions after surgery
British journal of surgery·2024· 3 citedOpen Access
Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the <scp>Australasian Lymphoma Alliance</scp>
Internal Medicine Journal·2024· 2 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

David Cunningham(22), Nicola Valeri(10), William Allum(9), Florian Lordick(8), Matteo Fassan(7), Andrés Cervantes(7), Andrea Lampis(6), Ian Chau(6), Jens C. Hahne(6), Jesper Lagergren(6), Andrew Wotherspoon(6), Ruth E. Langley(6), Heike I. Grabsch(5), Chiara Braconi(5), Clare Peckitt(5), Matthew Nankivell(5), Josep Tabernero(5), George Pentheroudakis(5), Eric Van Cutsem(5), Kohei Shitara(5)